Induction of prostaglandin E2 synthesis and microsomal prostaglandin E synthase–1 expression in murine microglia by glioma-derived soluble factors

Laboratory investigation

Restricted access

Object

Microglia are one of the members of monocyte/macrophage lineage in the central nervous system (CNS) and exist as ramified microglia in a normal resting state, but they are activated by various stimuli, such as tumors. Activated microglia induce immune responses in the CNS, but the precise functions of microglia in glioma microenvironments are not clear. It has been reported that glioma cells produce prostaglandin (PG)E2, which promotes the growth of tumor cells and possesses immunosuppressive activity. The authors previously reported that PGE2 production by peritoneal macrophages was enhanced by glioma-derived soluble factors, which induce an immunosuppressive state. In this study, they investigated PGE2 production by microglia treated with glioma cells and assessed the role of microglia in glioma microenvironments in the mouse.

Methods

Microglia and peritoneal macrophages were cultured in vitro with or without lipopolysaccharide, and tumor necrosis factor (TNF) and PGE2 in the culture supernatant were measured using L929 bioassay and enzyme immunoassay. The expression of mRNA was measured using reverse transcriptase polymerase chain reaction, and the protein expression was assayed with Western blotting. In some experiments glioma cells and conditioned glioma medium were added to the microglia cultures.

Results

Glioma cells studied in this report did not produce a significant amount of PGE2. However, the coculture of microglia with glioma cells or conditioned glioma medium led to the production of a large amount of PGE2. The enhancement of PGE2 production by microglia was more significant than that by peritoneal macrophages. The expression of cyclooxygenase (COX)–2 and particularly the expression of microsomal PGE synthase (mPGES)–1 (a terminal enzyme of the arachidonate cascade) in microglia were enhanced by conditioned glioma medium. The enhancement of mPGES-1 expression in microglia was more significant than that in peritoneal macrophages. The production of TNF was suppressed when culturing microglia with conditioned glioma medium, but this suppression was abrogated by the addition of a COX inhibitor (NS-398) and a PGE2 receptor (EP4) antagonist. Furthermore, TNF production was not suppressed in microglia from mPGES-1–deficient mice.

Conclusions

These results indicate that PGE2 production by microglia is enhanced by conditioned glioma medium, which induces an immunosuppressive state in the CNS. Therefore, the manipulation of microglia, from the standpoint of PGE2, provides investigators with an important strategy to induce an effective antiglioma immune response.

Abbreviations used in this paper: CNS = central nervous system; COX = cyclooxygenase; cPGES = cytosolic prostaglandin E synthase; cPLA2 = cytosolic phospholipase A2, FCS = fetal calf serum; G3PDH = glyceraldehyde-3-phosphate dehydrogenase; IL = interleukin; mPGES = microsomal PGE synthase; PGE2, PGH2 = prostaglandin E2, H2; RT-PCR = reverse transcriptase polymerase chain reaction; SDS-PAGE = sodium dodecyl sulfate–polyacrylamide gel electrophoresis; sPLA2 = secretory PLA2; TGFβ = transforming growth factor–β; TNF = tumor necrosis factor.
Article Information

Contributor Notes

Address correspondence to: Uki Yamashita, M.D., Ph.D., Department of Immunology, School of Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishiku, Kitakyushu 807-8555, Japan. email: yama-uki@med.uoeh-u.ac.jp.
Headings
References
  • 1

    Akaogi JYamada HKuroda YNacionales DCReeves WHSatoh M: Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-α and IL-6 production. J Leukoc Biol 76:2272362004

    • Search Google Scholar
    • Export Citation
  • 2

    Akasaki YLiu GChung NHEhtesham MBlack KLYu JS: Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma. J Immunol 173:435243592004

    • Search Google Scholar
    • Export Citation
  • 3

    Badie BBartley BSchartner J: Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomas. J Neuroimmunol 133:39452002

    • Search Google Scholar
    • Export Citation
  • 4

    Badie BSchartner J: Role of microglia in glioma biology. Microsc Res Tech 54:1061132001

  • 5

    Badie BSchartner JMHagar ARPrabakaran SPeebles TRBartley B: Microglia cyclooxygenase-2 activity in experimental gliomas: possible role in cerebral edema formation. Clin Cancer Res 9:8728772003

    • Search Google Scholar
    • Export Citation
  • 6

    Cserr HFKnopf PM: Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 13:5075121992

    • Search Google Scholar
    • Export Citation
  • 7

    Couldwell WTDore-Duffy PApuzzo MLAntel JP: Malignant glioma modulation of immune function: relative contribution of different soluble factors. J Neuroimmunol 33:89961991

    • Search Google Scholar
    • Export Citation
  • 8

    Flick DAGifford GE: Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 68:1671751984

  • 9

    Graeber MBScheithauer BWKreutzberg GW: Microglia in brain tumors. Glia 40:2522592002

  • 10

    Harding PBalasubramanian LSwegan JStevens AGlass WF II: Transforming growth factor beta regulates cyclooxygenase-2 in glomerular mesangial cells. Kidney Int 69:157815852006

    • Search Google Scholar
    • Export Citation
  • 11

    Harris SGPadilla JKoumas LRay DPhipps RP: Prostaglandins as modulators of immunity. Trends Immunol 23:1441502002

  • 12

    Jakobsson PJThorén SMorgentern RSamuelsson B: Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, including enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A 96:722072251999

    • Search Google Scholar
    • Export Citation
  • 13

    Joki THeese ONikas DCBello LZhang JKraeft SK: Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60:492649312000

    • Search Google Scholar
    • Export Citation
  • 14

    Katamura KShintaku NYamauchi YFukui TOhshima YMayumi M: Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. J Immunol 155:460446121995

    • Search Google Scholar
    • Export Citation
  • 15

    Kito TKuroda EYokota AYamashita U: Cytotoxicity in glioma cells due to interleukin-12 and interleukin-18-stimulated macrophages mediated by interferon-γ-regulated nitric oxide. J Neurosurg 98:3853922003

    • Search Google Scholar
    • Export Citation
  • 16

    Kito TKuroda EYokota AYamashita U: Enhancement of macrophage cytotoxicity against murine gliomas by interferon beta: increase in nitric oxide production in response to glioma-derived soluble factors. J Neurosurg 97:6196262002

    • Search Google Scholar
    • Export Citation
  • 17

    Kreutzberg GW: Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:3123181996

  • 18

    Kuroda EYamashita U: Mechanisms of enhanced macrophage-mediated prostaglandin E2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice. J Immunol 170:7577642003

    • Search Google Scholar
    • Export Citation
  • 19

    Kvirkvelia NVojnovic IWarner TDAthie-Morales VFree PRayment N: Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLA-2 T cells. Clin Exp Immunol 127:2632692002

    • Search Google Scholar
    • Export Citation
  • 20

    Loh JKHwang SLLieu ASHuang TYHowng SL: The alteration of prostaglandin E2 levels in patients with brain tumors before and after tumor removal. J Neurooncol 57:1471502002

    • Search Google Scholar
    • Export Citation
  • 21

    Machwate MHarada SLeu CTSeedor GLabelle MGallant S: Prostaglandin receptor EP4 mediates the bone anabolic effects of PGE2. Mol Pharmacol 60:36412001

    • Search Google Scholar
    • Export Citation
  • 22

    Murakami MNakashima KKamei DMasuda SIshikawa YIshii T: Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenase-1 and -2. J Biol Chem 278:37937379472003

    • Search Google Scholar
    • Export Citation
  • 23

    Nakano YKuroda EKito TYokota AYamashita U: Induction of macrophagic prostaglandin E2 synthesis by glioma cells. J Neurosurg 104:5745822006

    • Search Google Scholar
    • Export Citation
  • 24

    Ohyama KKikuchi HOda YMoritake KYamasaki T: [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells.]. No To Shinkei 45:5255301993. (Jpn)

    • Search Google Scholar
    • Export Citation
  • 25

    Okada KKuroda EYoshida YYamashita USuzumura ATsuji S: Effects of interferon-beta on the cytokine production of astrocytes. J Neuroimmunol 159:48542005

    • Search Google Scholar
    • Export Citation
  • 26

    Parney IFHao CPetruk KC: Glioma immunology and immunotherapy. Neurosurgery 46:7787922000

  • 27

    Rasley AMarriott IHalberstadt CRBost KLAnguita J: Substance P augments Borrelia burgdorferi-induced prostaglandin E2 production by murine microglia. J Immunol 172:570757132004

    • Search Google Scholar
    • Export Citation
  • 28

    Sawamura YDiserens ACdeTribolet N: In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes. J Neurooncol 9:1251301990

    • Search Google Scholar
    • Export Citation
  • 29

    Schartner JMHagar ARvan Handel MZhang LNadkarni NBadie B: Impaired capacity for upregulation of MHC class II in tumor-associated microglia. Glia 51:2792852005

    • Search Google Scholar
    • Export Citation
  • 30

    Shono TTofilon PJBruner JMOwolabi OLang FF: Cyclooxy-genase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 61:437543812001

    • Search Google Scholar
    • Export Citation
  • 31

    Streit WJ: Microglial response to brain injury: a brief synopsis. Toxicol Pathol 28:28302000

  • 32

    Streit WJWalter SAPennell NA: Reactive microgliosis. Prog Neurobiol 57:5635811999

  • 33

    Tanikawa NOhmiya YOhkubo HHashimoto KKanagawa KKojima M: Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 291:8848892002

    • Search Google Scholar
    • Export Citation
  • 34

    Tanioka TNakatani YSemmyo NMurakami MKudo I: Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 275:32775327822000

    • Search Google Scholar
    • Export Citation
  • 35

    Uematsu SMatsumoto MTakeda KAkira S: Lipopolysaccharide-dependent prostaglandin E2 production is regulated by the glutathione-dependent prostaglandin E2 synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J Immunol 168:581158162002

    • Search Google Scholar
    • Export Citation
  • 36

    van Rossum DHanisch UK: Microglia. Metab Brain Dis 19:3934112004

  • 37

    Wang TQin LLiu BLiu YWilson BEling TE: Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia. J Neurochem 88:9399472004

    • Search Google Scholar
    • Export Citation
  • 38

    Yamada MShimizu KMiyao YHayakawa TNakajima KNakahira K: Migration of genetically labeled glioma cells after implantation into murine brain. J Neurosci Res 38:4154231994

    • Search Google Scholar
    • Export Citation
TrendMD
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 215 162 17
Full Text Views 114 17 2
PDF Downloads 57 11 0
EPUB Downloads 0 0 0
PubMed
Google Scholar